Publication | Open Access
Routine Use of Intravenous Low-Dose Recombinant Tissue Plasminogen Activator in Japanese Patients
142
Citations
19
References
2009
Year
Three-month outcomes of patients receiving low-dose intravenous recombinant tissue plasminogen activator therapy in the present study were similar to those from postmarketing surveys using 0.9 mg/kg alteplase.
| Year | Citations | |
|---|---|---|
Page 1
Page 1